15:51:04Canada

Roivant Sciences Ltd. (ROIV)

NASDAQ

Key stats Fiscal year 2026

Income statement

Revenue
8,260,000 -71.6%
Net income
-299,771,000
Operating income
-515,068,000
Earnings per share
-0.54
R&D expense
681,812,000

Growth and profitability

Operating margin
-6,235.69
Net margin
-3,629.19
Free cash flow margin
-9,183.51

Cash flow and ratios

Operating cash flow
-750,349,000
Free cash flow
-758,558,000

Shareholder returns

Shares outstanding
724,561,460
Revenue and net income
From revenue to profit 2026
Debt, free cash flow and cash
Earnings per share

Company information

Headquarters
London
Exchange
NASDAQ
Fiscal year end
03-31
Industry (SEC)
Pharmaceutical Preparations

Fiscal year end: · Source: SEC EDGAR

Roivant Sciences Ltd. trades on NASDAQ under the ticker symbol ROIV. This page brings together its price chart, company profile, key financial figures and technical indicators.

Company profile

Technical analysis